Magnitude Of Birth Outcome After Induced Labor Among Mothers Delivered In Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital, Hosanna Town, Hadiya Zone, Southern Ethiopia. Cross-Sectional Study

Background “Induction of labor is not risk free, despite its importance for ending risky pregnancy compare to spontaneous onset of labor it has potential harms and it increases the rate of different maternal and neonatal complications.” Due to this WHO recommends IOL with only clear medical indications when the benefit more significant than potential harms. Even though there is a few study on IOL that address magnitude of birth outcome after IOL no study is found that determine the contributing factors to birth outcomes after IOL in Ethiopia especially in my study area, therefore the factors that affect the birth outcome after IOL need to be clearly understood. Objective To assess the magnitude birth outcome after induced labor and associated factor among child bearing mother who deliver in NEMMCSH in the last two years (January 01, 2019 to December 31, 2020 GC). Data was collected from June 25 to July 09, 2021 GC. Methods Hospital based retrospective cross-sectional study was conducted on 778 study participants selected by systematic random sampling technique among all child bearing mothers delivered by induction in NEMMCSH from January 01, 2019 to December 31, 2020 GC. Data was collected from patient cards, delivery registration log books and operation note books. Then data were entered and coded using EPI data version 3.1 and analyzed using SPSS version 25. Bivariate and multivariate logistic regression analysis was carried out to determine the association different potential factors with the birth outcome after IOL. Independent predictors were determined using adjusted odd ratio with 95% CL at p value < 0.05 in multivariate logistic regression analysis. Results In this study the magnitude of still birth after IOL was 9.6%. Rural residence [AOR=3.59; 95%CI:(1.32, 9.80)], maternal chronic medical diseases [AOR=3.58; 95% CL: (1.23, 10.41)], history of previous still birth [AOR=7.45; 95%CI: (2.45, 22.38)], Partograph use [AOR=0.034; 95%CI: 0.01,0.09)], delivering ˂8 hours[AOR=0.13; 95%CI: (0.03,0.56)] and delivering within 8-16[AOR=0.28; 95%CI:(0.10, 0.76)] hours were significant predictors for still birth. Conclusions The magnitude of still birth after IOL was relatively high in the study area. Variables which increase the likelihood of still birth were, living in rural area and previous history of still birth. The recommendations also forwarded for health care provider, NEMMCSH, different stakeholders and for researchers. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethical clearance was obtained from the Institutional Health Research Ethics Review Committee (IHRERC) Haramaya University, College of Health and Medical Sciences with Ethics approval number of IHRERC/074/2021. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All relevant data are within the manuscript and its Supporting Information files.